In the latter case, UCP2 does not act via a mild uncoupling but by rerouting the cancer-specific metabolic pathways and/or redox shuttles between mitochondria and cytosol to which it can amend a new transport mode (Figs. 9 and 16). The gene discussed is UCP2; the disease is cancer.